期刊
SAUDI JOURNAL OF GASTROENTEROLOGY
卷 18, 期 3, 页码 155-167出版社
WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/1319-3767.96445
关键词
Antifibrotic strategies; biochemical abnormalities; cell types; gene therapy; hepatic fibrosis
资金
- University Grants Commission (UGC) [DS Kothari-PDF]
- Department of Science & Technology (DST)
- Ministry of Science & Technology, New Delhi [DST/INSPIRE/2010/121]
Hepatic fibrosis (HF) is a progressive condition with serious clinical complications arising from abnormal proliferation and amassing of tough fibrous scar tissue. This defiance of collagen fibers becomes fatal due to ultimate failure of liver functions. Participation of various cell types, interlinked cellular events, and large number of mediator molecules make the fibrotic process enormously complex and dynamic. However, with better appreciation of underlying cellular and molecular mechanisms of fibrosis, the assumption that T-IF cannot be cured is gradually changing. Recent findings have underlined the therapeutic potential of a number of synthetic compounds as well as plant derivatives for cessation or even the reversal of the processes that transforms the liver into fibrotic tissue. It is expected that future inputs will provide a conceptual framework to develop more specific strategies that would facilitate the assessment of risk factors, shortlist early diagnosis biomarkers, and eventually guide development of effective therapeutic alternatives.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据